retatrutide phase 2 results obesity nejm 2023 in adults with over 104 weeks in the highest dose group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 obesity #retatrutide #weight #glp1 #nejm

This guide walks through how these drugs work, which patients benefit, what the trial data actually show, what to expect in terms of side effects and cost, and the difficult question of what happens when you stop

I dont judge them in any way, but I think those people are out of their minds. Injecting GLP-1 agonist drugs into the human body boosts the levels of hormones GLP-1 and GIP, which trigger the release of insulin into your bloodstream

The 5 mg formulation typically represents an intermediate titration dose used to evaluate patient response and minimize gastrointestinal side effects during dose escalation in clinical studies

When should I see a doctor about digestive side effects from retatrutide

All three are available privately for adults with a BMI of 30 or higher (or 27 with comorbidity), though the Wegovy pill isnt on the NHS yet